Drugs / esp remifentanyl (ultiva)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06264739 | Jan 2024 → Jan 2025 | — | Aydin Adnan Menderes University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | esp remifentanyl (ultiva) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06264739 ↗ |